We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VHC icon
826
VirnetX Holding Corp
VHC
$54.4M
– –
-719
Closed -$204K
VMC icon
827
Vulcan Materials
VMC
$37.4B
– –
-3,300
Closed -$219K
VRSN icon
828
VeriSign
VRSN
$25.4B
– –
-3,950
Closed -$213K
WHR icon
829
Whirlpool
WHR
$2.49B
– –
-1,550
Closed -$232K
WM icon
830
Waste Management
WM
$96.1B
– –
-9,040
Closed -$380K
WOLF icon
831
Wolfspeed
WOLF
$1.14B
– –
-33,592
Closed -$1.9M
FLG
832
Flagstar Bank National Association
FLG
$5.83B
– –
-3,413
Closed -$165K
BECN
833
DELISTED
Beacon Roofing Supply, Inc.
BECN
– –
-5,444
Closed -$210K
PRFT
834
DELISTED
Perficient Inc
PRFT
– –
-13,020
Closed -$236K
BBBY
835
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-7,937
Closed -$546K
MBII
836
DELISTED
Marrone Bio Innovations, Inc.
MBII
– –
-15,929
Closed -$223K
ATRS
837
DELISTED
Antares Pharma, Inc.
ATRS
– –
-12,950
Closed -$45K
XEC
838
DELISTED
CIMAREX ENERGY CO
XEC
– –
-2,050
Closed -$244K
WDR
839
DELISTED
Waddell & Reed Financial, Inc.
WDR
– –
-2,740
Closed -$202K
TTPH
840
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-1,163
Closed -$253K
PTLA
841
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-23,860
Closed -$618K
S
842
DELISTED
Sprint Corporation
S
– –
-24,560
Closed -$226K
PIR
843
DELISTED
Pier 1 Imports, Inc.
PIR
– –
-864
Closed -$326K
AVP
844
DELISTED
Avon Products, Inc.
AVP
– –
-13,970
Closed -$205K
LLL
845
DELISTED
L3 Technologies, Inc.
LLL
– –
-2,910
Closed -$344K
SSNI
846
DELISTED
Silver Spring Networks, Inc.
SSNI
– –
-11,307
Closed -$197K
KATE
847
DELISTED
Kate Spade & Company
KATE
– –
-6,910
Closed -$256K
XXIA
848
DELISTED
Ixia
XXIA
– –
-12,391
Closed -$155K
CSC
849
DELISTED
Computer Sciences
CSC
– –
-8,543
Closed -$219K
IQNT
850
DELISTED
Inteliquent, Inc.
IQNT
– –
-21,588
Closed -$314K
31 32 33
34
35

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.